Dr. Eric Vigneault
Claim this profileCHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
7 reported clinical trials
24 drugs studied
Area of expertise
1Prostate Cancer
metastatic
localized
testosterone
2Prostate Adenocarcinoma
Affiliated Hospitals
Clinical Trials Eric Vigneault is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
High vs Low Dose Rate Brachytherapy
for Prostate Cancer
The purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy chosen for this study as well as a commonly used alternate form of brachytherapy called low dose rate (or seed) brachytherapy. Investigators would like to understand how these treatments control the prostate cancer and look at their short and long term treatment related side effects. The dose of radiation for HDR brachytherapy for this study has been changed since the study started. Other studies using the dose of radiation for HDR brachytherapy that was originally chosen for this study (Arm 2) found that this dose of radiation may be linked to a greater chance of the cancer coming back in the prostate. Therefore since March 2020, for new participants entering the study, a new HDR brachytherapy arm with a higher amount of radiation given over two doses will be tested in this study
Recruiting1 award N/A
More about Eric Vigneault
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Eric Vigneault has experience with
- Bicalutamide
- Histrelin
- Leuprolide
- Triptorelin
- Goserelin
- Flutamide
Breakdown of trials Eric Vigneault has run
Prostate Cancer
Prostate Adenocarcinoma
Bone Metastasis
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Vigneault specialize in?
Eric Vigneault focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved metastatic patients, or patients who are localized.
Is Eric Vigneault currently recruiting for clinical trials?
Yes, Eric Vigneault is currently recruiting for 4 clinical trials in Quebec City Quebec. If you're interested in participating, you should apply.
Are there any treatments that Eric Vigneault has studied deeply?
Yes, Eric Vigneault has studied treatments such as Bicalutamide, Histrelin, Leuprolide.
What is the best way to schedule an appointment with Eric Vigneault?
Apply for one of the trials that Eric Vigneault is conducting.
What is the office address of Eric Vigneault?
The office of Eric Vigneault is located at: CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec G1R 2J6 Canada. This is the address for their practice at the CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.